N/A
N/A
BIOGRAPHICAL SKETCH EZIO GIACOBINI, MD, PhD Ezio Giacobini, MD, PhD was from 1995 to 2020 a Professor associated with the Department of Internal Medicine, Rehabilitation and Geriatrics at the University of Geneva Faculty of Medicine and the University Hospital Geneva. His major research interests are both in the pre-clinical and clinical development of drug therapy for Alzheimer’s disease. Together with Robert Becker, he has developed, preclinically and clinically, two new cholinesterase inhibitors (Metrifonate and Pentastigmine) and participated in the clinical development of E20-20 (Donepezil), Rivastigmine and Phenserine. He is the author of over 300 peer-reviewed publications in international journals in the field of pharmacology, psychiatry and neurology. He also authored books, book chapters and articles in the field of neuropharmacology of the cholinergic system with a special interest in the area of Alzheimer’s disease therapy and cholinesterase inhibitors. He was the founder and organizer of the international meeting Advances in Alzheimer’s Therapy from 1988 to 2018. He received in July 2002, the Life Time Achievement Award in Alzheimer’s Disease Research from the Alzheimer Association (USA) at the 8th International Conference on Alzheimer’s Disease in Stockholm.

Moderator of 3 Sessions

PLENARY LECTURE
Session Type
PLENARY LECTURE
Date
Wed, 16.03.2022
Session Time
12:00 PM - 12:30 PM
Room
ONSITE PLENARY: 115-117
Session Type
SYMPOSIUM
Date
Thu, 17.03.2022
Session Time
09:10 AM - 11:10 AM
Room
ONSITE: 114
Session Type
SYMPOSIUM
Date
Sun, 20.03.2022
Session Time
09:05 AM - 11:05 AM
Room
ONSITE: 113

Presenter of 2 Presentations

Discussants

Session Type
FORUM
Date
Fri, 18.03.2022
Session Time
03:50 PM - 04:50 PM
Room
ONSITE PLENARY: 115-117
Lecture Time
03:50 PM - 04:50 PM

IN MEMORIAM of Giancarlo Pepeu

Session Type
OTHER EVENT
Date
Wed, 16.03.2022
Session Time
11:00 AM - 11:30 AM
Room
ONSITE PLENARY: 115-117
Lecture Time
11:07 AM - 11:11 AM